|
KMID : 0191120160310071055
|
|
Journal of Korean Medical Science
2016 Volume.31 No. 7 p.1055 ~ p.1062
|
|
|
High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk or Recurrent Bone and Soft Tissue Sarcomas
|
|
Choi Young-Bae
Yi Eun-Sang
Lee Ji-Won
Yoo Keon-Hee
Sung Ki-Woong
Koo Hong-Hoe
|
|
|
Abstract
|
|
|
|
Despite increasing evidence that high-dose chemotherapy and autologous stem cell transplantation (HDCT/auto-SCT) might improve the survival of patients with high-risk or recurrent solid tumors, therapy effectiveness for bone and soft tissue sarcoma treatment remains unclear. This study retrospectively investigated the feasibility and effectiveness of HDCT/auto-SCT for high-risk or recurrent bone and soft tissue sarcoma. A total of 28 patients (18 high-risk and 10 recurrent) underwent single or tandem HDCT/auto-SCT between October 2004 and September 2014. During follow-up of a median 15.3 months, 18 patients exhibited disease progression and 2 died of treatment-related toxicities (1 veno-occlusive disease and 1 sepsis). Overall, 8 patients remained alive and progression-free. The 3-year overall survival (OS) and event-free survival (EFS) rates for all 28 patients were 28.7% and 26.3%, respectively. In the subgroup analysis, OS and EFS rates were higher in patients with complete or partial remission prior to HDCT/auto-SCT than in those with worse responses (OS, 39.1% vs. 0.0%, P = 0.002; EFS, 36.8% vs. 0.0%, P < 0.001). Therefore, careful selection of patients who can benefit from HDCT/auto-SCT and maximal effort to reduce tumor burden prior to treatment will be important to achieve favorable outcomes in patients with high-risk or recurrent bone and soft tissue sarcomas.
|
|
|
KEYWORD
|
|
|
Bone and Soft Tissue Sarcoma, Children, High-Dose Chemotherapy, Autologous Stem Cell Transplantation
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|